Pfizer Raises 2025 Profit Outlook Amid Strong Quarterly Results
Pfizer raised its 2025 profit guidance due to cost reductions and strong quarterly performance, surpassing Wall Street estimates with a revenue of $14.65 billion in Q2, and maintaining its revenue forecast despite potential tariffs and drug price pressures.